ALEXANDRIA, Va., Feb. 5 -- United States Patent no. 12,214,021, issued on Feb. 4, was assigned to CHINA AGRICULTURAL UNIVERSITY (Beijing).

"Study on lactoferrin regulation of bone formation by means of vitamin D receptor" was invented by Huiyuan Guo (Beijing), Yixuan Li (Beijing), Hao Zhang (Beijing) and Liang Zhao (Beijing).

According to the abstract* released by the U.S. Patent & Trademark Office: "A use of lactoferrin in the preparation of a food or drug, the food or drug being used for activating a VDR signaling pathway, which is used for the treatment of bone disease, bone disease comprising: osteoporosis, bone damage, loss of bone calcium, incomplete bone development and bone abnormalities. The present invention further comprises sc...